SCHEMBL7186623

SCHEMBL7186623

COc1ccc(C(C)(C)C)c(OC)c1/C=C/C(=O)c1ccc(OCOC(=O)C(C)(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ABCG2 Q9UNQ0 6/20 0.44
TNFRSF1A P19438 2/20 0.43
KRAS P01116 1/20 0.42
ABCC1 P33527 1/20 0.41
DPP4 P27487 2/20 0.40
PTPN1 P18031 3/20 0.40
MAOB P27338 1/20 0.40
EGFR P00533 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MAOA P21397 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186626 1.00 KDM4E (0.46) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7186101 0.89 KDM4E (0.47) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7186107 0.89 KDM4E (0.47) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7182356 0.88 PPARA (0.39) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7182353 0.88 PPARA (0.39) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7180721 0.87 MAOB (0.43) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7180730 0.87 MAOB (0.43) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7184535 0.87 TNFRSF1A (0.48) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7184543 0.87 TNFRSF1A (0.48) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7180091 0.87 PTPN1 (0.50) KDM4ELMNAMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed